COMPARE
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option vs Nippon India Power & Infra Fund - Direct Plan Growth Plan - Growth Option
Nippon India Pharma Fund and Nippon India Power & Infra Fund are both in the Sectoral Fund category, from Nippon Life India Asset Management Limited. Nippon India Pharma Fund has posted a higher 3-year rolling CAGR. Nippon India Pharma Fund has the lower expense ratio. See the full table and FAQ below for the complete real-data comparison.
Basics
Nippon India Pharma Fund has the lower direct-plan expense ratio, by 0.10 percentage points.
| Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | Nippon India Power & Infra Fund - Direct Plan Growth Plan - Growth Option | |
|---|---|---|
| Category | Sectoral Fund | Sectoral Fund |
| AMC | Nippon Life India Asset Management Limited | Nippon Life India Asset Management Limited |
| Benchmark | BSE Healthcare TRI | Nifty Infrastructure TRI |
| NAV | ₹620.0717 (2026-10-28) | ₹382.3478 (2026-10-28) |
| AUM | ₹8,635.041 Cr | ₹7,467.512 Cr |
| Expense Ratio (Direct) | 1% | 1.1% |
| Inception | 2004-05-10 | 2004-03-29 |
Returns
Nippon India Pharma Fund leads on 3-year rolling CAGR (19.8% vs Nippon India Power & Infra Fund's 18.0%) - see the FAQ below for percentile context within each fund's own category.
Risk Metrics
Nippon India Power & Infra Fund has been the more volatile of the two by standard deviation.
Portfolio Analytics
Nippon India Pharma Fund carries the higher portfolio P/E ratio (a rougher proxy for how richly the underlying holdings are valued) - see the table below for the full comparison.
| Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | Nippon India Power & Infra Fund - Direct Plan Growth Plan - Growth Option | |
|---|---|---|
| P/E Ratio | 39.6786 | 24.2147 |
| P/B Ratio | 12.3627 | 9.9087 |
| Dividend Yield | 0.724% | 1.0342% |
| Active Share | 40.74% | 67.11% |
| Portfolio Turnover | 15% | 46% |
| YTM | - | - |
| Duration (Macaulay) | - | - |
Punji Fund Health Score
Nippon India Pharma Fund and Nippon India Power & Infra Fund carry the same Punji Quality grade.
Frequently asked questions
Which has a higher 3-year return, Nippon India Pharma Fund or Nippon India Power & Infra Fund?
Nippon India Pharma Fund's 3-year rolling CAGR of 19.8% is higher than Nippon India Power & Infra Fund's 18.0%. Nippon India Pharma Fund sits in the 67th percentile of its category on this metric, versus the 33rd percentile for Nippon India Power & Infra Fund - though note both funds may belong to different categories with different medians, so a raw CAGR comparison doesn't account for how each fund performed relative to its own peers. A higher historical return also doesn't necessarily mean lower risk; check the risk metrics below before concluding either fund is the "better" choice.
Which has a lower expense ratio, Nippon India Pharma Fund or Nippon India Power & Infra Fund?
Nippon India Pharma Fund's direct-plan expense ratio is 0.10 percentage points lower than Nippon India Power & Infra Fund's. Over long holding periods, a persistent expense-ratio gap compounds into a materially different final corpus even if the two funds' gross returns are similar - it's one of the few fund attributes you can compare with total certainty upfront, unlike future returns, since the fee is contractually fixed rather than a historical estimate.
Which fund carries more risk, Nippon India Pharma Fund or Nippon India Power & Infra Fund?
By standard deviation (a measure of how much a fund's returns swing around its own average), Nippon India Power & Infra Fund has been more volatile than Nippon India Pharma Fund over the trailing window. Standard deviation captures total volatility in both directions - up and down - so a higher figure means bigger swings generally, not necessarily bigger losses specifically. Sharpe ratio (0.61 for Nippon India Pharma Fund vs 0.36 for Nippon India Power & Infra Fund) is a better single measure of risk-adjusted return, since it weighs the return earned per unit of volatility taken rather than volatility alone.
Which has higher AUM, Nippon India Pharma Fund or Nippon India Power & Infra Fund?
Nippon India Pharma Fund has ₹8,635 Cr in assets under management, versus ₹7,468 Cr for Nippon India Power & Infra Fund. A larger AUM generally means deeper liquidity and lower per-unit fixed costs for the AMC to spread across investors, but an AUM that's very large relative to a fund's category and strategy (especially in small/mid cap categories, where the investable universe is smaller) can also make it harder for a manager to enter and exit positions without moving the price - bigger isn't automatically better, especially for less liquid categories.
Which fund has a longer track record, Nippon India Pharma Fund or Nippon India Power & Infra Fund?
Nippon India Power & Infra Fund launched on 2004-03-29, making it older than Nippon India Pharma Fund (launched 2004-05-10). A longer track record means more real market cycles (bull runs, corrections, rate cycles) the fund has actually navigated, which is useful context for judging consistency - but it isn't a guarantee of future performance, and a newer fund isn't automatically worse, especially if it's run by an experienced manager or team with a track record at a prior fund.
Data as of 2026-10-29. Source: AMFI disclosures via Punji. Not investment advice.